Dr. Kavanaugh has conducted research sponsored by UCB and has received consulting fees (less than $10,000) from UCB.
Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis†
Article first published online: 29 OCT 2009
Copyright © 2009 by the American College of Rheumatology
Arthritis Care & Research
Volume 61, Issue 11, pages 1592–1600, 15 November 2009
How to Cite
Kavanaugh, A., Smolen, J. S., Emery, P., Purcaru, O., Keystone, E., Richard, L., Strand, V. and van Vollenhoven, R. F. (2009), Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis. Arthritis & Rheumatism, 61: 1592–1600. doi: 10.1002/art.24828
ClinicalTrials.gov identifiers: RAPID 1, NCT00152386; RAPID 2, NCT00160602.
- Issue published online: 29 OCT 2009
- Article first published online: 29 OCT 2009
- Manuscript Accepted: 29 JUN 2009
- Manuscript Received: 16 FEB 2009
- UCB Pharma
- 2Arthritis and employment research: where are we? Where do we need to go? J Rheumatol Suppl 2005; 72: 42–5..
- 10OMERACT: Outcome Measures in Rheumatology. URL: www.omeract.org.
- 18Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial. Ann Rheum Dis 2006; 65: 899–904., , , , , , et al.
- 22Clinical and radiological effects of anakinra in patients with rheumatoid arthritis. Rheumatology (Oxford) 2003; 42 Suppl 2: ii22–8., .
- 25Effect of adalimumab combination therapy on work performance: results from a companion study to PREMIER [abstract]. Ann Rheum Dis 2007; 66 Suppl 2: 192., , , , .
- 26Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two–week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum 2008; 58: 3319–29., , , , , , et al.